A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer’s disease
Cholinesterase (ChE) enzymes have been identified as diagnostic markers for Alzheimer disease (AD). Substrate-based probes have been synthesised to detect ChEs but they have not detected changes in ChE distribution associated with AD pathology. Probes are typically screened using spectrophotometric...
Main Authors: | Sultan Darvesh, Scott Banfield, Maeve Dufour, Katrina L. Forrestall, Hillary Maillet, G. Andrew Reid, Dane Sands, Ian R. Pottie |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2225797 |
Similar Items
-
Characterization of placental cholinesterases and activity induction associated to environmental organophosphate exposure
by: S. Sánchez, et al.
Published: (2015-01-01) -
Identification of cholinesterases inhibitors from flavonoids derivatives for possible treatment of Alzheimer's disease: In silico and in vitro approaches
by: Morteza Sadeghi, et al.
Published: (2024-01-01) -
Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease
by: Ana Matošević, et al.
Published: (2024-11-01) -
First-in-Class Isonipecotamide-Based Thrombin and Cholinesterase Dual Inhibitors with Potential for Alzheimer Disease
by: Rosa Purgatorio, et al.
Published: (2021-08-01) -
Cholinesterase inhibitors isolated from bilberry fruit
by: Kamila Borowiec, et al.
Published: (2014-11-01)